fda approval for tirzepatide GROUNDBREAKING UPDATE! has approved TIRZEPATIDE, a pioneering obesity treatment activating GIP & GLP-1 receptors, weight loss! Previously, has been FDA approved for type 2 diabetes as Mounjaro, and although F.D.A. Approves New Obesity Drug

It can be overwhelmed, especially if poor handling introduces a significant microbial load

In the Nurses Health Study II [14], increases in BMI were linked to a progressive increase in the risk of developing psoriasis

Establish a skincare routine that supports skin health

We can learn valuable lessons from companies like Tesla and Apple to see how they collect user data to continually improve their products for both current and new customers

HOURS PORTLAND 9am-6pm, Daily LAKE OSWEGO 9am - 5pm, Monday - Friday QUICK LINKS Information on this website is provided for educational and informational purposes only and does not constitute medical advice

Our medical team provides guidance, adjustments, and encouragement throughout treatment to support long-term success and overall well-being